Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Y Sheng

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Case Reports in Oncological Medicine|December 31, 2025
Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab-RelatlimabRohit Rao, Felicia Tejawinata, Tejasi Sachdeva, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
American Journal of Clinical Oncology|June 28, 2024
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma PatientsKathleen M Mulligan, Hanna Kakish, Omkar Pawar, et al.
Targeted Oncology|July 15, 2020
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and PrednisoneIris Y Sheng, Jaleh Fallah, Ruby Gupta, et al.
Clinical Genitourinary Cancer|November 6, 2023
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell CarcinomaJames Schuster, Iris Y Sheng, Chandana A Reddy, et al.
Vaccines|July 30, 2025
Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive ReviewAyushi Garg, Rohit Rao, Felicia Tejawinata, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
The Oncologist|November 26, 2025
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer CenterKevin G Zablonski, Jarred M Boone, Seunghee Margevicius, et al.
Annals of Surgical Oncology|December 16, 2025
Is Ultrasound-Based Imaging Essential for Melanoma Active Surveillance?Natalie N Chakraborty, Maira Bhatty, Kevin G Zablonski, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Case Reports in Oncological Medicine|December 31, 2025
Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab-RelatlimabRohit Rao, Felicia Tejawinata, Tejasi Sachdeva, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
American Journal of Clinical Oncology|June 28, 2024
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma PatientsKathleen M Mulligan, Hanna Kakish, Omkar Pawar, et al.
Targeted Oncology|July 15, 2020
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and PrednisoneIris Y Sheng, Jaleh Fallah, Ruby Gupta, et al.
Clinical Genitourinary Cancer|November 6, 2023
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell CarcinomaJames Schuster, Iris Y Sheng, Chandana A Reddy, et al.
Vaccines|July 30, 2025
Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive ReviewAyushi Garg, Rohit Rao, Felicia Tejawinata, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2018
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal CancerHoward Safran, Kara-Lynne Leonard, Kimberly Perez, et al.
The Oncologist|November 26, 2025
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer CenterKevin G Zablonski, Jarred M Boone, Seunghee Margevicius, et al.
Annals of Surgical Oncology|December 16, 2025
Is Ultrasound-Based Imaging Essential for Melanoma Active Surveillance?Natalie N Chakraborty, Maira Bhatty, Kevin G Zablonski, et al.
Pageof 3